NOW ENROLLING: CANaspire, Aspa’s investigational gene therapy trial for patients with Canavan disease.
Families can visit www.treatcanavan.com to learn more or click here to register interest.

Aspa Therapeutics Presents Update on CANaspire Gene Therapy Trial for Canavan Disease at ESGCT 2024. Details can be found here.